Skip to main content

Table 1 (abstract P14). National Essential Medicines List (NEML) evolution 1996-2011

From: Abstracts from the 4th International PPRI Conference 2019: Medicines access challenge – The value of pricing and reimbursement policies

Year of NEML approval

Total number of molecules (excluding duplicates)

Total number of molecules (including duplicates)

Total number of pharmaceutical forms

Rate of pharmaceutical form per molecule

Total number of therapeutic categories

1996

106

108

147

1.36

0

2007

475

504

718

1.42

29

2009

519

578

819

1.41

27

2011

576

635

856

1.34

29